nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—melanoma	0.137	1	CbGaD
Pimozide—CYP2E1—Dacarbazine—melanoma	0.0673	0.141	CbGbCtD
Pimozide—CYP1A2—Carmustine—melanoma	0.0643	0.134	CbGbCtD
Pimozide—CYP1A2—Vemurafenib—melanoma	0.0508	0.106	CbGbCtD
Pimozide—CYP3A4—Temozolomide—melanoma	0.0486	0.102	CbGbCtD
Pimozide—CYP2D6—Vemurafenib—melanoma	0.0419	0.0875	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—melanoma	0.0389	0.0814	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0312	0.0653	CbGbCtD
Pimozide—CYP3A7—Docetaxel—melanoma	0.0312	0.0653	CbGbCtD
Pimozide—ABCB1—Dactinomycin—melanoma	0.0295	0.0617	CbGbCtD
Pimozide—CYP3A4—Vemurafenib—melanoma	0.0266	0.0557	CbGbCtD
Pimozide—CYP3A5—Docetaxel—melanoma	0.0234	0.049	CbGbCtD
Pimozide—ABCB1—Docetaxel—melanoma	0.0152	0.0319	CbGbCtD
Pimozide—CYP3A4—Docetaxel—melanoma	0.00913	0.0191	CbGbCtD
Pimozide—Tonic-clonic seizures—Carmustine—melanoma	0.00394	0.0388	CcSEcCtD
Pimozide—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00313	0.0308	CcSEcCtD
Pimozide—Periorbital oedema—Bleomycin—melanoma	0.00308	0.0303	CcSEcCtD
Pimozide—Abnormal behaviour—Temozolomide—melanoma	0.00276	0.0271	CcSEcCtD
Pimozide—CALM2—ear—melanoma	0.00248	0.0659	CbGeAlD
Pimozide—CALM1—ear—melanoma	0.00247	0.0656	CbGeAlD
Pimozide—Grand mal convulsion—Carmustine—melanoma	0.00223	0.022	CcSEcCtD
Pimozide—Faecal incontinence—Carmustine—melanoma	0.0021	0.0207	CcSEcCtD
Pimozide—Faecal incontinence—Temozolomide—melanoma	0.00203	0.02	CcSEcCtD
Pimozide—HTR2A—hindlimb—melanoma	0.00156	0.0414	CbGeAlD
Pimozide—Extrapyramidal disorder—Temozolomide—melanoma	0.00136	0.0134	CcSEcCtD
Pimozide—HTR2A—appendage—melanoma	0.00133	0.0355	CbGeAlD
Pimozide—CALM2—endothelium—melanoma	0.00133	0.0354	CbGeAlD
Pimozide—CALM1—endothelium—melanoma	0.00132	0.0352	CbGeAlD
Pimozide—CALM2—hair follicle—melanoma	0.00131	0.0348	CbGeAlD
Pimozide—Eosinophilia—Vemurafenib—melanoma	0.00125	0.0123	CcSEcCtD
Pimozide—Endocrine disorder—Temozolomide—melanoma	0.00124	0.0122	CcSEcCtD
Pimozide—Speech disorder—Carmustine—melanoma	0.00123	0.0122	CcSEcCtD
Pimozide—CALM2—blood vessel—melanoma	0.00122	0.0326	CbGeAlD
Pimozide—CALM1—blood vessel—melanoma	0.00122	0.0325	CbGeAlD
Pimozide—Speech disorder—Temozolomide—melanoma	0.00119	0.0117	CcSEcCtD
Pimozide—Amenorrhoea—Temozolomide—melanoma	0.00117	0.0115	CcSEcCtD
Pimozide—Weight decreased—Vemurafenib—melanoma	0.00114	0.0112	CcSEcCtD
Pimozide—CACNA1G—head—melanoma	0.00113	0.03	CbGeAlD
Pimozide—Aplastic anaemia—Dactinomycin—melanoma	0.00107	0.0105	CcSEcCtD
Pimozide—Connective tissue disorder—Vemurafenib—melanoma	0.000991	0.00976	CcSEcCtD
Pimozide—Aplastic anaemia—Temozolomide—melanoma	0.000964	0.00949	CcSEcCtD
Pimozide—Gynaecomastia—Carmustine—melanoma	0.00095	0.00936	CcSEcCtD
Pimozide—Eye disorder—Vemurafenib—melanoma	0.000942	0.00928	CcSEcCtD
Pimozide—Cardiac disorder—Vemurafenib—melanoma	0.000936	0.00922	CcSEcCtD
Pimozide—CALM2—neck—melanoma	0.000876	0.0233	CbGeAlD
Pimozide—CALM1—neck—melanoma	0.000872	0.0232	CbGeAlD
Pimozide—CALM3—eye—melanoma	0.00083	0.0221	CbGeAlD
Pimozide—CALM3—retina—melanoma	0.000822	0.0219	CbGeAlD
Pimozide—HTR2A—endothelium—melanoma	0.000805	0.0214	CbGeAlD
Pimozide—DRD3—head—melanoma	0.000804	0.0214	CbGeAlD
Pimozide—Amenorrhoea—Docetaxel—melanoma	0.000777	0.00765	CcSEcCtD
Pimozide—Hyponatraemia—Carmustine—melanoma	0.000774	0.00762	CcSEcCtD
Pimozide—HTR6—head—melanoma	0.000774	0.0206	CbGeAlD
Pimozide—Myalgia—Vemurafenib—melanoma	0.000747	0.00736	CcSEcCtD
Pimozide—HTR2A—blood vessel—melanoma	0.000743	0.0198	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000742	0.00731	CcSEcCtD
Pimozide—Pancytopenia—Bleomycin—melanoma	0.000725	0.00714	CcSEcCtD
Pimozide—OPRK1—head—melanoma	0.000717	0.0191	CbGeAlD
Pimozide—Dysphagia—Dactinomycin—melanoma	0.000712	0.00701	CcSEcCtD
Pimozide—Nervous system disorder—Vemurafenib—melanoma	0.000703	0.00692	CcSEcCtD
Pimozide—Skin disorder—Vemurafenib—melanoma	0.000696	0.00685	CcSEcCtD
Pimozide—Weight decreased—Bleomycin—melanoma	0.000691	0.0068	CcSEcCtD
Pimozide—Pancytopenia—Dactinomycin—melanoma	0.000676	0.00666	CcSEcCtD
Pimozide—Breast disorder—Temozolomide—melanoma	0.000673	0.00663	CcSEcCtD
Pimozide—Hypotension—Vemurafenib—melanoma	0.000669	0.00659	CcSEcCtD
Pimozide—Dysphagia—Carmustine—melanoma	0.000666	0.00656	CcSEcCtD
Pimozide—CALM3—mammalian vulva—melanoma	0.000658	0.0175	CbGeAlD
Pimozide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000653	0.00643	CcSEcCtD
Pimozide—CALM2—eye—melanoma	0.000652	0.0173	CbGeAlD
Pimozide—CALM1—eye—melanoma	0.000649	0.0173	CbGeAlD
Pimozide—CALM2—retina—melanoma	0.000646	0.0172	CbGeAlD
Pimozide—Dysphagia—Temozolomide—melanoma	0.000644	0.00634	CcSEcCtD
Pimozide—CALM1—retina—melanoma	0.000643	0.0171	CbGeAlD
Pimozide—Pancytopenia—Carmustine—melanoma	0.000633	0.00623	CcSEcCtD
Pimozide—Decreased appetite—Vemurafenib—melanoma	0.000623	0.00613	CcSEcCtD
Pimozide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000619	0.00609	CcSEcCtD
Pimozide—Constipation—Vemurafenib—melanoma	0.000613	0.00603	CcSEcCtD
Pimozide—Pancytopenia—Temozolomide—melanoma	0.000611	0.00602	CcSEcCtD
Pimozide—DRD2—eye—melanoma	0.000599	0.016	CbGeAlD
Pimozide—Pollakiuria—Temozolomide—melanoma	0.000595	0.00586	CcSEcCtD
Pimozide—DRD2—retina—melanoma	0.000594	0.0158	CbGeAlD
Pimozide—Erectile dysfunction—Temozolomide—melanoma	0.000593	0.00584	CcSEcCtD
Pimozide—Depression—Carmustine—melanoma	0.000592	0.00583	CcSEcCtD
Pimozide—Agranulocytosis—Dactinomycin—melanoma	0.000592	0.00583	CcSEcCtD
Pimozide—Weight increased—Temozolomide—melanoma	0.000586	0.00577	CcSEcCtD
Pimozide—Weight decreased—Temozolomide—melanoma	0.000583	0.00574	CcSEcCtD
Pimozide—Depression—Temozolomide—melanoma	0.000572	0.00564	CcSEcCtD
Pimozide—CALM2—skin of body—melanoma	0.000567	0.0151	CbGeAlD
Pimozide—CALM1—skin of body—melanoma	0.000564	0.015	CbGeAlD
Pimozide—HTR2A—neck—melanoma	0.000531	0.0141	CbGeAlD
Pimozide—Connective tissue disorder—Carmustine—melanoma	0.000524	0.00516	CcSEcCtD
Pimozide—Visual disturbance—Docetaxel—melanoma	0.000523	0.00515	CcSEcCtD
Pimozide—CALM2—mammalian vulva—melanoma	0.000517	0.0138	CbGeAlD
Pimozide—CALM1—mammalian vulva—melanoma	0.000515	0.0137	CbGeAlD
Pimozide—Asthenia—Vemurafenib—melanoma	0.000514	0.00506	CcSEcCtD
Pimozide—Visual impairment—Carmustine—melanoma	0.000514	0.00506	CcSEcCtD
Pimozide—OPRM1—head—melanoma	0.00051	0.0136	CbGeAlD
Pimozide—Pruritus—Vemurafenib—melanoma	0.000507	0.00499	CcSEcCtD
Pimozide—Connective tissue disorder—Temozolomide—melanoma	0.000506	0.00499	CcSEcCtD
Pimozide—Eye disorder—Carmustine—melanoma	0.000498	0.00491	CcSEcCtD
Pimozide—Hyponatraemia—Docetaxel—melanoma	0.000497	0.0049	CcSEcCtD
Pimozide—Visual impairment—Temozolomide—melanoma	0.000497	0.00489	CcSEcCtD
Pimozide—Anaemia—Bleomycin—melanoma	0.000492	0.00484	CcSEcCtD
Pimozide—Diarrhoea—Vemurafenib—melanoma	0.00049	0.00483	CcSEcCtD
Pimozide—ABCB1—blood vessel—melanoma	0.000487	0.013	CbGeAlD
Pimozide—Eye disorder—Temozolomide—melanoma	0.000482	0.00474	CcSEcCtD
Pimozide—Cardiac disorder—Temozolomide—melanoma	0.000478	0.00471	CcSEcCtD
Pimozide—Leukopenia—Bleomycin—melanoma	0.000476	0.00469	CcSEcCtD
Pimozide—Dizziness—Vemurafenib—melanoma	0.000474	0.00467	CcSEcCtD
Pimozide—HRH1—eye—melanoma	0.000473	0.0126	CbGeAlD
Pimozide—Mental disorder—Carmustine—melanoma	0.000467	0.0046	CcSEcCtD
Pimozide—CHRM2—head—melanoma	0.000464	0.0124	CbGeAlD
Pimozide—Anaemia—Dactinomycin—melanoma	0.000458	0.00451	CcSEcCtD
Pimozide—Vomiting—Vemurafenib—melanoma	0.000456	0.00449	CcSEcCtD
Pimozide—Chest pain—Bleomycin—melanoma	0.000453	0.00446	CcSEcCtD
Pimozide—Myalgia—Bleomycin—melanoma	0.000453	0.00446	CcSEcCtD
Pimozide—Orthostatic hypotension—Docetaxel—melanoma	0.000452	0.00446	CcSEcCtD
Pimozide—Rash—Vemurafenib—melanoma	0.000452	0.00445	CcSEcCtD
Pimozide—Mental disorder—Temozolomide—melanoma	0.000452	0.00445	CcSEcCtD
Pimozide—Dermatitis—Vemurafenib—melanoma	0.000451	0.00444	CcSEcCtD
Pimozide—Headache—Vemurafenib—melanoma	0.000449	0.00442	CcSEcCtD
Pimozide—Breast disorder—Docetaxel—melanoma	0.000448	0.00441	CcSEcCtD
Pimozide—Cramp muscle—Docetaxel—melanoma	0.000446	0.00439	CcSEcCtD
Pimozide—Leukopenia—Dactinomycin—melanoma	0.000444	0.00437	CcSEcCtD
Pimozide—Vision blurred—Carmustine—melanoma	0.000438	0.00431	CcSEcCtD
Pimozide—Tremor—Carmustine—melanoma	0.000435	0.00428	CcSEcCtD
Pimozide—Anaemia—Carmustine—melanoma	0.000429	0.00423	CcSEcCtD
Pimozide—Dysphagia—Docetaxel—melanoma	0.000428	0.00422	CcSEcCtD
Pimozide—Agitation—Carmustine—melanoma	0.000427	0.0042	CcSEcCtD
Pimozide—Nausea—Vemurafenib—melanoma	0.000426	0.00419	CcSEcCtD
Pimozide—Vision blurred—Temozolomide—melanoma	0.000423	0.00416	CcSEcCtD
Pimozide—Myalgia—Dactinomycin—melanoma	0.000422	0.00416	CcSEcCtD
Pimozide—Tremor—Temozolomide—melanoma	0.00042	0.00414	CcSEcCtD
Pimozide—Leukopenia—Carmustine—melanoma	0.000416	0.00409	CcSEcCtD
Pimozide—Anaemia—Temozolomide—melanoma	0.000415	0.00408	CcSEcCtD
Pimozide—Anorexia—Bleomycin—melanoma	0.000414	0.00407	CcSEcCtD
Pimozide—Agitation—Temozolomide—melanoma	0.000412	0.00406	CcSEcCtD
Pimozide—Pancytopenia—Docetaxel—melanoma	0.000407	0.004	CcSEcCtD
Pimozide—Hypotension—Bleomycin—melanoma	0.000406	0.00399	CcSEcCtD
Pimozide—Convulsion—Carmustine—melanoma	0.000402	0.00396	CcSEcCtD
Pimozide—Leukopenia—Temozolomide—melanoma	0.000402	0.00395	CcSEcCtD
Pimozide—Hypertension—Carmustine—melanoma	0.000401	0.00395	CcSEcCtD
Pimozide—Palpitations—Temozolomide—melanoma	0.000396	0.0039	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000395	0.00389	CcSEcCtD
Pimozide—Chest pain—Carmustine—melanoma	0.000395	0.00389	CcSEcCtD
Pimozide—Myalgia—Carmustine—melanoma	0.000395	0.00389	CcSEcCtD
Pimozide—HTR2A—eye—melanoma	0.000395	0.0105	CbGeAlD
Pimozide—HTR2A—retina—melanoma	0.000392	0.0104	CbGeAlD
Pimozide—Weight increased—Docetaxel—melanoma	0.00039	0.00384	CcSEcCtD
Pimozide—Convulsion—Temozolomide—melanoma	0.000389	0.00383	CcSEcCtD
Pimozide—Weight decreased—Docetaxel—melanoma	0.000387	0.00381	CcSEcCtD
Pimozide—Hypertension—Temozolomide—melanoma	0.000387	0.00381	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—melanoma	0.000386	0.0038	CcSEcCtD
Pimozide—Myalgia—Temozolomide—melanoma	0.000382	0.00376	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000379	0.00374	CcSEcCtD
Pimozide—Decreased appetite—Bleomycin—melanoma	0.000377	0.00372	CcSEcCtD
Pimozide—HTR1A—head—melanoma	0.000376	0.01	CbGeAlD
Pimozide—HRH1—mammalian vulva—melanoma	0.000375	0.00999	CbGeAlD
Pimozide—Dry mouth—Temozolomide—melanoma	0.000374	0.00368	CcSEcCtD
Pimozide—CALM2—head—melanoma	0.00037	0.00985	CbGeAlD
Pimozide—Tachycardia—Carmustine—melanoma	0.00037	0.00364	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000369	0.00363	CcSEcCtD
Pimozide—CALM1—head—melanoma	0.000368	0.0098	CbGeAlD
Pimozide—Anorexia—Carmustine—melanoma	0.000361	0.00356	CcSEcCtD
Pimozide—Nervous system disorder—Temozolomide—melanoma	0.000359	0.00354	CcSEcCtD
Pimozide—Agranulocytosis—Docetaxel—melanoma	0.000356	0.00351	CcSEcCtD
Pimozide—Skin disorder—Temozolomide—melanoma	0.000356	0.0035	CcSEcCtD
Pimozide—Hypotension—Carmustine—melanoma	0.000354	0.00349	CcSEcCtD
Pimozide—Hyperhidrosis—Temozolomide—melanoma	0.000354	0.00349	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—melanoma	0.000352	0.00347	CcSEcCtD
Pimozide—Anorexia—Temozolomide—melanoma	0.000349	0.00344	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Carmustine—melanoma	0.000345	0.0034	CcSEcCtD
Pimozide—Urticaria—Bleomycin—melanoma	0.000345	0.0034	CcSEcCtD
Pimozide—Insomnia—Carmustine—melanoma	0.000343	0.00337	CcSEcCtD
Pimozide—DRD2—head—melanoma	0.00034	0.00905	CbGeAlD
Pimozide—Somnolence—Carmustine—melanoma	0.000337	0.00332	CcSEcCtD
Pimozide—Connective tissue disorder—Docetaxel—melanoma	0.000337	0.00332	CcSEcCtD
Pimozide—KCNH2—head—melanoma	0.000335	0.00892	CbGeAlD
Pimozide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000334	0.00328	CcSEcCtD
Pimozide—Insomnia—Temozolomide—melanoma	0.000331	0.00326	CcSEcCtD
Pimozide—Visual impairment—Docetaxel—melanoma	0.00033	0.00325	CcSEcCtD
Pimozide—CALM3—lymph node—melanoma	0.00033	0.00878	CbGeAlD
Pimozide—Decreased appetite—Carmustine—melanoma	0.000329	0.00324	CcSEcCtD
Pimozide—Gastrointestinal disorder—Carmustine—melanoma	0.000327	0.00322	CcSEcCtD
Pimozide—Somnolence—Temozolomide—melanoma	0.000326	0.00321	CcSEcCtD
Pimozide—Constipation—Carmustine—melanoma	0.000324	0.00319	CcSEcCtD
Pimozide—Eye disorder—Docetaxel—melanoma	0.00032	0.00315	CcSEcCtD
Pimozide—Decreased appetite—Temozolomide—melanoma	0.000318	0.00313	CcSEcCtD
Pimozide—Cardiac disorder—Docetaxel—melanoma	0.000318	0.00313	CcSEcCtD
Pimozide—Gastrointestinal disorder—Temozolomide—melanoma	0.000316	0.00311	CcSEcCtD
Pimozide—Constipation—Temozolomide—melanoma	0.000313	0.00308	CcSEcCtD
Pimozide—Asthenia—Bleomycin—melanoma	0.000311	0.00307	CcSEcCtD
Pimozide—Pruritus—Bleomycin—melanoma	0.000307	0.00302	CcSEcCtD
Pimozide—Mental disorder—Docetaxel—melanoma	0.0003	0.00296	CcSEcCtD
Pimozide—Urticaria—Temozolomide—melanoma	0.000291	0.00286	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—melanoma	0.00029	0.00286	CcSEcCtD
Pimozide—Muscle spasms—Docetaxel—melanoma	0.000287	0.00282	CcSEcCtD
Pimozide—Diarrhoea—Dactinomycin—melanoma	0.000277	0.00273	CcSEcCtD
Pimozide—Vomiting—Bleomycin—melanoma	0.000276	0.00272	CcSEcCtD
Pimozide—Anaemia—Docetaxel—melanoma	0.000276	0.00272	CcSEcCtD
Pimozide—Rash—Bleomycin—melanoma	0.000274	0.00269	CcSEcCtD
Pimozide—Dermatitis—Bleomycin—melanoma	0.000273	0.00269	CcSEcCtD
Pimozide—Asthenia—Carmustine—melanoma	0.000272	0.00268	CcSEcCtD
Pimozide—HRH1—head—melanoma	0.000269	0.00715	CbGeAlD
Pimozide—Syncope—Docetaxel—melanoma	0.000268	0.00263	CcSEcCtD
Pimozide—Leukopenia—Docetaxel—melanoma	0.000267	0.00263	CcSEcCtD
Pimozide—Palpitations—Docetaxel—melanoma	0.000264	0.0026	CcSEcCtD
Pimozide—Asthenia—Temozolomide—melanoma	0.000263	0.00259	CcSEcCtD
Pimozide—Loss of consciousness—Docetaxel—melanoma	0.000262	0.00258	CcSEcCtD
Pimozide—Diarrhoea—Carmustine—melanoma	0.000259	0.00255	CcSEcCtD
Pimozide—Pruritus—Temozolomide—melanoma	0.000259	0.00255	CcSEcCtD
Pimozide—CALM2—lymph node—melanoma	0.000259	0.0069	CbGeAlD
Pimozide—Convulsion—Docetaxel—melanoma	0.000259	0.00255	CcSEcCtD
Pimozide—CYP2E1—head—melanoma	0.000258	0.00687	CbGeAlD
Pimozide—CALM1—lymph node—melanoma	0.000258	0.00686	CbGeAlD
Pimozide—Nausea—Bleomycin—melanoma	0.000258	0.00254	CcSEcCtD
Pimozide—Hypertension—Docetaxel—melanoma	0.000258	0.00254	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—melanoma	0.000257	0.00253	CcSEcCtD
Pimozide—ABCB1—retina—melanoma	0.000257	0.00683	CbGeAlD
Pimozide—Rash—Dactinomycin—melanoma	0.000255	0.00251	CcSEcCtD
Pimozide—Myalgia—Docetaxel—melanoma	0.000254	0.0025	CcSEcCtD
Pimozide—Chest pain—Docetaxel—melanoma	0.000254	0.0025	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000252	0.00248	CcSEcCtD
Pimozide—Dizziness—Carmustine—melanoma	0.000251	0.00247	CcSEcCtD
Pimozide—Diarrhoea—Temozolomide—melanoma	0.000251	0.00247	CcSEcCtD
Pimozide—Dry mouth—Docetaxel—melanoma	0.000248	0.00245	CcSEcCtD
Pimozide—Dizziness—Temozolomide—melanoma	0.000242	0.00238	CcSEcCtD
Pimozide—Vomiting—Carmustine—melanoma	0.000241	0.00237	CcSEcCtD
Pimozide—Nausea—Dactinomycin—melanoma	0.00024	0.00237	CcSEcCtD
Pimozide—Shock—Docetaxel—melanoma	0.00024	0.00236	CcSEcCtD
Pimozide—Rash—Carmustine—melanoma	0.000239	0.00235	CcSEcCtD
Pimozide—Nervous system disorder—Docetaxel—melanoma	0.000239	0.00235	CcSEcCtD
Pimozide—Dermatitis—Carmustine—melanoma	0.000239	0.00235	CcSEcCtD
Pimozide—Tachycardia—Docetaxel—melanoma	0.000238	0.00234	CcSEcCtD
Pimozide—Headache—Carmustine—melanoma	0.000237	0.00234	CcSEcCtD
Pimozide—Skin disorder—Docetaxel—melanoma	0.000237	0.00233	CcSEcCtD
Pimozide—KCNH2—lymph node—melanoma	0.000235	0.00625	CbGeAlD
Pimozide—Vomiting—Temozolomide—melanoma	0.000233	0.00229	CcSEcCtD
Pimozide—Anorexia—Docetaxel—melanoma	0.000232	0.00229	CcSEcCtD
Pimozide—Rash—Temozolomide—melanoma	0.000231	0.00227	CcSEcCtD
Pimozide—Dermatitis—Temozolomide—melanoma	0.000231	0.00227	CcSEcCtD
Pimozide—Headache—Temozolomide—melanoma	0.000229	0.00226	CcSEcCtD
Pimozide—Hypotension—Docetaxel—melanoma	0.000228	0.00224	CcSEcCtD
Pimozide—Nausea—Carmustine—melanoma	0.000225	0.00222	CcSEcCtD
Pimozide—HTR2A—head—melanoma	0.000224	0.00597	CbGeAlD
Pimozide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000222	0.00218	CcSEcCtD
Pimozide—Insomnia—Docetaxel—melanoma	0.00022	0.00217	CcSEcCtD
Pimozide—Nausea—Temozolomide—melanoma	0.000217	0.00214	CcSEcCtD
Pimozide—Somnolence—Docetaxel—melanoma	0.000216	0.00213	CcSEcCtD
Pimozide—Decreased appetite—Docetaxel—melanoma	0.000212	0.00208	CcSEcCtD
Pimozide—Gastrointestinal disorder—Docetaxel—melanoma	0.00021	0.00207	CcSEcCtD
Pimozide—Constipation—Docetaxel—melanoma	0.000208	0.00205	CcSEcCtD
Pimozide—ABCB1—mammalian vulva—melanoma	0.000205	0.00547	CbGeAlD
Pimozide—CYP2D6—head—melanoma	0.000204	0.00544	CbGeAlD
Pimozide—HRH1—lymph node—melanoma	0.000188	0.00501	CbGeAlD
Pimozide—Ezetimibe—ABCB1—melanoma	0.000183	0.297	CrCbGaD
Pimozide—Astemizole—ABCB1—melanoma	0.000183	0.297	CrCbGaD
Pimozide—Asthenia—Docetaxel—melanoma	0.000175	0.00172	CcSEcCtD
Pimozide—Pruritus—Docetaxel—melanoma	0.000172	0.0017	CcSEcCtD
Pimozide—Diarrhoea—Docetaxel—melanoma	0.000167	0.00164	CcSEcCtD
Pimozide—Dizziness—Docetaxel—melanoma	0.000161	0.00159	CcSEcCtD
Pimozide—Vomiting—Docetaxel—melanoma	0.000155	0.00152	CcSEcCtD
Pimozide—Rash—Docetaxel—melanoma	0.000154	0.00151	CcSEcCtD
Pimozide—Dermatitis—Docetaxel—melanoma	0.000153	0.00151	CcSEcCtD
Pimozide—Headache—Docetaxel—melanoma	0.000153	0.0015	CcSEcCtD
Pimozide—ABCB1—head—melanoma	0.000147	0.00391	CbGeAlD
Pimozide—Nausea—Docetaxel—melanoma	0.000145	0.00142	CcSEcCtD
Pimozide—Fexofenadine—ABCB1—melanoma	0.00013	0.212	CrCbGaD
Pimozide—Domperidone—ABCB1—melanoma	0.000119	0.193	CrCbGaD
Pimozide—ABCB1—lymph node—melanoma	0.000103	0.00274	CbGeAlD
Pimozide—CYP3A4—Metabolism—ABCB1—melanoma	2.83e-06	1.16e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK1—melanoma	2.81e-06	1.15e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—melanoma	2.81e-06	1.15e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—melanoma	2.8e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CB—melanoma	2.8e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTEN—melanoma	2.8e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTEN—melanoma	2.8e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—melanoma	2.79e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—melanoma	2.79e-06	1.14e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—melanoma	2.79e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—melanoma	2.78e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—melanoma	2.78e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—melanoma	2.78e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—melanoma	2.78e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—melanoma	2.78e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—melanoma	2.78e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.77e-06	1.13e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—melanoma	2.76e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—melanoma	2.74e-06	1.12e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—melanoma	2.74e-06	1.12e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—melanoma	2.74e-06	1.12e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK1—melanoma	2.74e-06	1.12e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—melanoma	2.74e-06	1.12e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—melanoma	2.73e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK1—melanoma	2.72e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK1—melanoma	2.72e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—melanoma	2.72e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—melanoma	2.72e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—melanoma	2.71e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—melanoma	2.71e-06	1.11e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—melanoma	2.71e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—melanoma	2.69e-06	1.1e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—melanoma	2.67e-06	1.09e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—melanoma	2.67e-06	1.09e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—melanoma	2.67e-06	1.09e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—melanoma	2.66e-06	1.09e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—melanoma	2.65e-06	1.08e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—melanoma	2.65e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—melanoma	2.64e-06	1.08e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—melanoma	2.64e-06	1.08e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—melanoma	2.64e-06	1.08e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—melanoma	2.64e-06	1.08e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—melanoma	2.63e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—melanoma	2.63e-06	1.07e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—melanoma	2.63e-06	1.07e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—melanoma	2.63e-06	1.07e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—melanoma	2.61e-06	1.06e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PRKCA—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—melanoma	2.6e-06	1.06e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—melanoma	2.59e-06	1.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—melanoma	2.59e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—melanoma	2.58e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—melanoma	2.58e-06	1.06e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—melanoma	2.58e-06	1.05e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ERCC2—melanoma	2.58e-06	1.05e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—melanoma	2.57e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—melanoma	2.57e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—melanoma	2.57e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—melanoma	2.56e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—melanoma	2.56e-06	1.05e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—melanoma	2.56e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—melanoma	2.56e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—melanoma	2.55e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—melanoma	2.55e-06	1.04e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—melanoma	2.55e-06	1.04e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—melanoma	2.55e-06	1.04e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—melanoma	2.55e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—melanoma	2.54e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—melanoma	2.54e-06	1.04e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—melanoma	2.54e-06	1.04e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—melanoma	2.53e-06	1.03e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—melanoma	2.53e-06	1.03e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—melanoma	2.51e-06	1.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—melanoma	2.51e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—melanoma	2.49e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—melanoma	2.49e-06	1.02e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—melanoma	2.49e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—melanoma	2.49e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—melanoma	2.49e-06	1.02e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—melanoma	2.48e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—melanoma	2.48e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—melanoma	2.47e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—melanoma	2.47e-06	1.01e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—melanoma	2.46e-06	1e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—melanoma	2.44e-06	9.98e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—melanoma	2.44e-06	9.97e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—melanoma	2.44e-06	9.97e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—melanoma	2.44e-06	9.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—melanoma	2.43e-06	9.93e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—melanoma	2.42e-06	9.9e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—melanoma	2.42e-06	9.9e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—melanoma	2.42e-06	9.9e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—melanoma	2.42e-06	9.89e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—melanoma	2.42e-06	9.88e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—melanoma	2.42e-06	9.87e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—melanoma	2.42e-06	9.86e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK1—melanoma	2.41e-06	9.83e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NFKB1—melanoma	2.41e-06	9.83e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—melanoma	2.41e-06	9.83e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—melanoma	2.4e-06	9.8e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—melanoma	2.4e-06	9.8e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—melanoma	2.39e-06	9.76e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—melanoma	2.38e-06	9.71e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—melanoma	2.38e-06	9.71e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK1—melanoma	2.37e-06	9.67e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—melanoma	2.37e-06	9.67e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—melanoma	2.37e-06	9.67e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK1—melanoma	2.36e-06	9.65e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—melanoma	2.36e-06	9.65e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—melanoma	2.36e-06	9.64e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—melanoma	2.36e-06	9.64e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—melanoma	2.36e-06	9.63e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—melanoma	2.36e-06	9.62e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—melanoma	2.36e-06	9.62e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—melanoma	2.35e-06	9.61e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—melanoma	2.35e-06	9.61e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—melanoma	2.34e-06	9.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—melanoma	2.34e-06	9.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—melanoma	2.34e-06	9.55e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—melanoma	2.34e-06	9.55e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—melanoma	2.34e-06	9.54e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NFKB1—melanoma	2.33e-06	9.51e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NFKB1—melanoma	2.33e-06	9.51e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK1—melanoma	2.33e-06	9.5e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—melanoma	2.32e-06	9.49e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—melanoma	2.32e-06	9.49e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—melanoma	2.32e-06	9.46e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—melanoma	2.3e-06	9.4e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—melanoma	2.29e-06	9.36e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—melanoma	2.28e-06	9.32e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—melanoma	2.28e-06	9.32e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—melanoma	2.27e-06	9.28e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—melanoma	2.26e-06	9.23e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—melanoma	2.26e-06	9.23e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—melanoma	2.25e-06	9.2e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—melanoma	2.25e-06	9.19e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—melanoma	2.25e-06	9.17e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—melanoma	2.24e-06	9.13e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—melanoma	2.23e-06	9.12e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—melanoma	2.23e-06	9.11e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—melanoma	2.2e-06	8.99e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—melanoma	2.2e-06	8.97e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—melanoma	2.19e-06	8.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—melanoma	2.18e-06	8.92e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—melanoma	2.18e-06	8.9e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—melanoma	2.18e-06	8.9e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—melanoma	2.16e-06	8.83e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—melanoma	2.16e-06	8.81e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—melanoma	2.16e-06	8.81e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—melanoma	2.16e-06	8.8e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—melanoma	2.11e-06	8.63e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—melanoma	2.11e-06	8.63e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—melanoma	2.11e-06	8.6e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—melanoma	2.09e-06	8.54e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—melanoma	2.09e-06	8.54e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—melanoma	2.09e-06	8.53e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—melanoma	2.09e-06	8.52e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—melanoma	2.09e-06	8.52e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—melanoma	2.09e-06	8.52e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—melanoma	2.09e-06	8.52e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—melanoma	2.09e-06	8.51e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—melanoma	2.09e-06	8.51e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—melanoma	2.07e-06	8.44e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—melanoma	2.07e-06	8.43e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.06e-06	8.39e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—melanoma	2.05e-06	8.38e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—melanoma	2.05e-06	8.37e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—melanoma	2.05e-06	8.37e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—melanoma	2.04e-06	8.33e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—melanoma	2.04e-06	8.33e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—melanoma	2.02e-06	8.27e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—melanoma	2.02e-06	8.25e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.02e-06	8.24e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—melanoma	2.01e-06	8.21e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—melanoma	2.01e-06	8.19e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—melanoma	2e-06	8.16e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—melanoma	2e-06	8.16e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—melanoma	1.99e-06	8.13e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—melanoma	1.99e-06	8.12e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—melanoma	1.98e-06	8.1e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—melanoma	1.97e-06	8.06e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—melanoma	1.97e-06	8.06e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—melanoma	1.97e-06	8.04e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK1—melanoma	1.97e-06	8.03e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—melanoma	1.97e-06	8.03e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—melanoma	1.95e-06	7.97e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—melanoma	1.94e-06	7.94e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—melanoma	1.94e-06	7.94e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—melanoma	1.94e-06	7.94e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—melanoma	1.93e-06	7.89e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—melanoma	1.93e-06	7.86e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—melanoma	1.93e-06	7.86e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK1—melanoma	1.9e-06	7.77e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK1—melanoma	1.9e-06	7.77e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—melanoma	1.9e-06	7.76e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—melanoma	1.9e-06	7.76e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—melanoma	1.9e-06	7.76e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—melanoma	1.9e-06	7.75e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—melanoma	1.87e-06	7.62e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—melanoma	1.86e-06	7.58e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—melanoma	1.85e-06	7.55e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—melanoma	1.82e-06	7.43e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—melanoma	1.82e-06	7.42e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—melanoma	1.8e-06	7.34e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—melanoma	1.8e-06	7.34e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—melanoma	1.79e-06	7.32e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—melanoma	1.79e-06	7.3e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—melanoma	1.77e-06	7.23e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—melanoma	1.75e-06	7.15e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—melanoma	1.71e-06	6.97e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—melanoma	1.71e-06	6.97e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—melanoma	1.68e-06	6.86e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—melanoma	1.68e-06	6.85e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—melanoma	1.68e-06	6.84e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—melanoma	1.67e-06	6.84e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—melanoma	1.67e-06	6.81e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—melanoma	1.65e-06	6.74e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—melanoma	1.65e-06	6.74e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—melanoma	1.65e-06	6.74e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—melanoma	1.65e-06	6.73e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—melanoma	1.61e-06	6.58e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—melanoma	1.61e-06	6.58e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—melanoma	1.6e-06	6.52e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—melanoma	1.6e-06	6.52e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—melanoma	1.58e-06	6.47e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—melanoma	1.58e-06	6.45e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—melanoma	1.56e-06	6.38e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—melanoma	1.55e-06	6.32e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—melanoma	1.55e-06	6.31e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—melanoma	1.53e-06	6.23e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—melanoma	1.53e-06	6.23e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—melanoma	1.51e-06	6.17e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—melanoma	1.46e-06	5.97e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—melanoma	1.46e-06	5.97e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—melanoma	1.46e-06	5.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—melanoma	1.39e-06	5.69e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—melanoma	1.35e-06	5.51e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—melanoma	1.35e-06	5.51e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—melanoma	1.35e-06	5.51e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—melanoma	1.29e-06	5.28e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	5.16e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—melanoma	1.23e-06	5.04e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—melanoma	1.19e-06	4.86e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—melanoma	1.01e-06	4.12e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—melanoma	9.53e-07	3.89e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—melanoma	7.78e-07	3.18e-06	CbGpPWpGaD
